Neuroprotective Effects of β-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK/Bcl-2/Beclin-1 Pathway

Molecular Neurobiology

Volumn 53, Issue 1, 2016, Pages 83-94

  Zhang, Sheng ^a   Gui, Xue Hong ^a   Huang, Li Ping ^a   Deng, Min Zhen ^a   Fang, Ruo Ming ^a   Ke, Xue Hong ^a   He, Yu Ping ^a   Li, Ling ^a   Fang, Yong Qi ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Autophagy; Beclin 1; JNK; Neuroprotection; Parkinson s disease; asarone

Indexed keywords

3 METHYLADENINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; ALPHA SYNUCLEIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BECLIN 1; BETA ASARONE; HOMOVANILLIC ACID; NEUROTRANSMITTER; OXIDOPAMINE; PROTEIN BCL 2; PROTEIN P62; RAPAMYCIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TYROSINE 3 MONOOXYGENASE; ANISOLE DERIVATIVE; APOPTOSIS REGULATORY PROTEIN; ASARONE; BECN1 PROTEIN, RAT; DOPAMINE; NEUROPROTECTIVE AGENT;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOWN REGULATION; DRUG EFFECT; DRUG MEGADOSE; IN VIVO STUDY; LOW DRUG DOSE; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPEN FIELD TEST; PARKINSON DISEASE; PARKINSONISM; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ROTAROD TEST; SEROTONIN BRAIN LEVEL; ANIMAL; APOPTOSIS; DRUG EFFECTS; METABOLISM; PARKINSONIAN DISORDERS; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANISOLES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BECLIN-1; CORPUS STRIATUM; DOPAMINE; MALE; MAP KINASE SIGNALING SYSTEM; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS, SPRAGUE-DAWLEY;

EID: 84953367411     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8950-z     Document Type: Article

References (52)

1. Chung KK, Dawson VL, Dawson TM (2003) New insights into Parkinson’s disease. J Neurol 250:15–24
2. Li L, Wang X, Fei X, Xia L, Qin Z, Liang Z (2011) Parkinson’s disease involves autophagy and abnormal distribution of cathepsin L. Neurosci Lett 489:62–67
3. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292–1295
4. Trenti A, Grumati P, Cusinato F, Orso G, Bonaldo P, Trevisi L (2014) Cardiac glycoside ouabain induces autophagic cell death in non-small cell lung cancer cells via a JNK-dependent decrease of Bcl-2. Biochem Pharmacol 89:197–209
5. Shimizu S, Konishi A, Nishida Y, Mizuta T, Nishina H, Yamamoto A, Tsujimoto Y (2010) Involvement of JNK in the regulation of autophagic cell death. Oncogene 29:2070–2082
6. Castro-Caldas M, Carvalho AN, Rodrigues E, Henderson C, Wolf CR, Gama MJ (2012) Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway. Mol Neurobiol 45:466–477
7. Chambers JW, Howard S, LoGrasso PV (2013) Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo. J Biol Chem 288:1079–1087
8. Chambers JW, Pachori A, Howard S, Ganno M, Hansen D Jr, Kamenecka T, Song X, Duckett D, Chen W, Ling YY, Cherry L, Cameron MD, Lin L, Ruiz CH, Lograsso P (2011) Small molecule c-jun-N-terminal Kinase (JNK) inhibitors protect dopaminergic neurons in a model of Parkinson’s Disease. ACS Chem Neurosci 2:198–206
9. Pan J, Qian J, Zhang Y, Ma J, Wang G, Xiao Q, Chen S, Ding J (2010) Small peptide inhibitor of JNKs protects against MPTP-induced nigral dopaminergic injury via inhibiting the JNK-signaling pathway. Lab Invest 90:156–167
10. Crocker CE, Khan S, Cameron MD, Robertson HA, Robertson GS, Lograsso P (2011) JNK inhibition protects dopamine neurons and provides behavioral improvement in a rat 6-hydroxydopamine model of Parkinson’s disease. ACS Chem Neurosci 2:207–212
11. Fang YQ, Shi C, Liu L, Fang RM (2012) Pharmacokinetics of beta-asarone in rabbit blood, hippocampus, cortex, brain stem, thalamus and cerebellum. Pharmazie 67:120–123
12. Gang W, Yun-bo C, Dong-Feng C, Xiao-Ping L, Dong-Hui L, Ru-Dong D, Jian-Hong Z, Sai-Xia Z, Yi-Wei L, Hui L, Liu-Fang L, Qi W, Hui N (2013) β-asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AβPP/PS1 Mice. J Alzheimers Dis 33:863–880
13. Chengchong L, Guihua X, Miaoxian D, Li Z, Jiaming L, Gang W, Dejia Z, Rui W, Jicheng L, Yingcai N (2010) Beta-asarone protection against beta-amyloid-induced neurotoxicity in PC12 cells via JNK signaling and modulation of Bcl-2 family proteins. Eur J Pharmacol 635:96–102
14. Yutao G, Chengchong L, Jicheng L, Guihua X, Li Z, Miaoxian D, Xueyan L, Yingcai N (2010) Beta-Asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection Rats. Biol Pharm Bull 33:836–843
15. De-Jia Z, Gang W, Ji-Cheng L, Miao-Xian D, Xiao-Ming L, Chun Z, Li Z, Rui W, Ying-Cai N (2011) Beta-asarone attenuates beta-amyloid-induced apoptosis through the inhibition of the activation of apoptosis signal-regulating kinase 1 in SH-SY5Y cells. Pharmazie 66:45–51
16. Zhiqiang L, Guoping Z, Sanqi Q, Zijun Y, Xiaoyin C, Jia C, Chuan C, Xue bing L, Jun G (2012) Cerebrovascular protection of β-asarone in Alzheimer’s disease rats: a behavioral, cerebral blood flow, biochemical and genic study. J Ethnopharmacol 144:305–312
17. Chen Y, Wei G, Nie H, Lin Y, Tian H, Liu Y, Yu X, Cheng S, Yan R, Wang Q, Liu DH, Deng W, Lai Y, Zhou JH, Zhang SX, Lin WW, Chen DF (2014) β-Asarone prevents autophagy and synaptic loss by reducing ROCK expression in asenescence-accelerated prone 8 mice. Brain Res 1552:41–54
18. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic, San Diego
19. Shin KY, Won BY, Heo C, Kim HJ, Jang DP, Park CH, Kim S, Kim HS, Kim YB, Lee HG, Lee SH, Cho ZH, Suh YH (2009) BT-11 improves stress-induced memory impairments through increment of glucose utilization and total neural cell adhesion molecule levels in rat brains. J Neurosci Res 87:260–268
20. Hennis MR, Seamans KW, Marvin MA, Casey BH, Goldberg MS (2013) Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and Superoxide Dismutase. Plos One 8:e84894
21. Olsson M, Nikkhah G, Bentlage C, Björklund A (1995) Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15:3863–3875
22. West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482–497
23. Mizushima N (2004) Methods for monitoring autophagy. Int J Biochem Cell Biol 36:2491–2502
24. He Y, Mo Z, Xue Z, Fang Y (2013) Establish a flow cytometric method for quantitative detection of Beclin-1 expression. Cytotechnology 65:481–489
25. Liu L, Fang Y-Q, Xue Z-F, He Y-P, Fang R-M, Li L (2012) Beta-asarone attenuates ischemia-reperfusion-induced autophagy in rat brains via modulating JNK, p-JNK, Bcl-2 and Beclin 1. European J Pharmacol 680:34–40
26. Anastasia A, Torre L, de Erausquin GA, Masco DH (2009) Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson’s disease. J Neurochem 109:755–765
27. Bankiewicz KS, Sanchez-Pernaute R, Oiwa Y, Kohutnicka M, Cummins A, Eberling J (2001) Preclinical models of Parkinson’s disease. Curr Protoc Neurosci 9:9.4.1–9.4.32
28. Blandini F, Nappi G, Tassorelli C, Martignoni E (2000) Functional changes of the basal ganglia circuitry in Parkinson’s disease. Prog Neurobiol 62:63–88
29. Carta M, Lindgren HS, Lundblad M, Stancampiano R, Fadda F, Cenci MA (2006) Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats. J Neurochem 96:1718–1727
30. Morgese MG, Cassano T, Cuomo V, Giuffrida A (2007) Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson’s disease: role of CB(1) and TRPV1 receptors. Exp Neurol 208:110–119
31. Yan JQ, Yuan YH, Gao YN, Huang JY, Ma KL, Gao Y, Zhang WQ, Guo XF, Chen NH (2014) Overexpression of human E46K mutant α-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway. Mol Neurobiol 50:685–701
32. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N (2004) The role of autophagy during the early neonatal starvation period. Nature 432:1032–1036
33. Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy- lysosome pathway in neurodegeneration associated with Parkinson’s disease. Brain 131:1969–1978
34. Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283:23542–23556
35. Dagda RK, Cherra SJ 3rd, Kulich SM, Tandon A, Park D, Chu CT (2009) Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284:13843–13855
36. Jia-Hong L, Jie-Qiong T, Sundara Kumar Durairajan S, Liang-Feng L, Zhuo-Hua Z, Long M, Han-Ming S, Edwin Chan HY, Min L (2012) Isorhynchophylline, a natural alkaloid, promotes the degradation of a-synuclein in neuronal cells via inducing autophagy. Autophagy 8:98–108
37. Chen L-L, Song J-X, Lu J-H, Yuan Z-W, Liu L-F, Sundara Kumar Durairajan S, Li M (2014) Corynoxine, a natural autophagy enhancer, promotes the clearance of alpha-synuclein via Akt/mTOR pathway. J Neuroimmune Pharmacol 9:380–387
38. Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC (2007) Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 282:5641–5652
39. Bredesen DE, Rao RV, Mehlen P (2006) Cell death in the nervous system. Nature 443:796–802
40. Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L (2009) Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. Plos One 4:e5515
41. Yang Q, Mao Z (2009) The complexity in regulation of MEF2D by chaperone-mediated autophagy. Autophagy 5:1073–1074
42. Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, RakicP FRA (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A 101:665–670
43. Xia XG, Harding T, Weller M, Bieneman A, Uney JB, Schulz JB (2001) Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson’s disease. Proc Natl Acad Sci U S A 98:10433–10438
44. Kamenecka T, Jiang R, Song X, Duckett D, Chen W, Ling YY, Habel J, Laughlin JD, Chambers J, Figuera-Losada M, Cameron MD, Lin L, Ruiz CH, LoGrasso PV (2010) Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors. J Med Chem 53:419–431
45. Vaudano E, Rosenblad C, Bjorklund A (2001) Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor. Eur J Neurosci 113:1–14
46. Pan J, Zhao YX, Wang ZQ, Jin L, Sun ZK, Chen SD (2007) Expression of FasL and its interaction with Fas are mediated by c-Jun N-terminal kinase pathway in 6-OHDA-induced rat model of Parkinson disease. Neurosci Lett 428:82–87
47. Ganguly A, Oo TF, Rzhetskaya M, Pratt R, Yarygina O, Momoi T, Kholodilov N, Burke RE (2004) CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine. J Neurochem 88:469–480
48. Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005) The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:726–734
49. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8:741–752
50. Wei Y, Pattingre S, Sinha S, Bassik M, Levine B (2008) JNK1 -mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol Cell 30:678–688
51. Li DD, Wang LL, Deng R, Tang J, Shen Y, Guo JF, Wang Y, Xia LP, Feng GK, Liu QQ, Huang WL, Zeng YX, Zhu XF (2009) The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents induced autophagy in cancer cells. Oncogene 28:886–898
52. Park K-J, Lee S-H, Lee C-H, Jang J-Y, Chung J, Kwon M-H, Kim Y-S (2009) Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death. Biochem Biophys Res Commun 382:726–729